Lenbucod 10 mg/200 mg/350 mg FC tablets.
PDF Leaflet Revision Date: 02 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of mild to moderate pain of inflammatory origin.
Dosage (summary)
Adults and children over 12: 1-2 tablets every 6 hours, max 6 tablets/24 hours.
Onset of Action / Duration
Onset: 30-45 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in third trimester and breastfeeding; caution in first two trimesters.
Key Drug Interactions
- Anticoagulants
- MAOIs
- Other NSAIDs
Contraindications
- Hypersensitivity to components
- Active gastrointestinal bleeding
- Severe hepatic or renal impairment
- Children under 12 years
Common side effects
- Gastrointestinal disturbances
- Dizziness
- Skin rash
Counselling Points
- Do not exceed recommended dosage.
- Consult if symptoms persist or worsen.
- Avoid alcohol consumption.
Serious warnings
- Risk of gastrointestinal bleeding
- Potential for opioid dependence
- Severe skin reactions
Important Disclaimer
The Lenbucod 10 mg/200 mg/350 mg FC tablets. professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
